WISTA Trademark

Trademark Overview


On Tuesday, December 22, 2015, a trademark application was filed for WISTA with the United States Patent and Trademark Office. The USPTO has given the WISTA trademark a serial number of 79182923. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 22, 2023. This trademark is owned by WisTa Laboratories Ltd. The WISTA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and medical preparations for use in the detection, prevention and treatment of neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; chemical preparations for medical and pharmaceutical purposes for use in the detection, prevention and treatment of neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; none of the aforesaid being pharmaceutical preparations and substances intended for the prevention and treatment of bone/skeletal diseases

Medical, biological, biotechnological, genetic, and pharmaceutical research, design and development services and laboratory research services in the fields of drugs, pharmaceuticals and medicines; research, development and design of drugs and medicine; drug discovery services; laboratory and medical laboratory research and development services relating to drugs, pharmaceuticals and medicines; exploitation of scientific research and technology, namely, providing advice and information relating to scientific and technological research in the fields of drugs, pharmaceuticals and medicines, and in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing; researching and developing new products in the fields of drugs, pharmaceuticals and medicines; scientific research and development services in the fields of drug development, clinical ...
wista

General Information


Serial Number79182923
Word MarkWISTA
Filing DateTuesday, December 22, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 22, 2023
Registration Number5153172
Registration DateTuesday, March 7, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2016

Trademark Statements


Goods and ServicesPharmaceutical and medical preparations for use in the detection, prevention and treatment of neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; chemical preparations for medical and pharmaceutical purposes for use in the detection, prevention and treatment of neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; none of the aforesaid being pharmaceutical preparations and substances intended for the prevention and treatment of bone/skeletal diseases
Goods and ServicesMedical, biological, biotechnological, genetic, and pharmaceutical research, design and development services and laboratory research services in the fields of drugs, pharmaceuticals and medicines; research, development and design of drugs and medicine; drug discovery services; laboratory and medical laboratory research and development services relating to drugs, pharmaceuticals and medicines; exploitation of scientific research and technology, namely, providing advice and information relating to scientific and technological research in the fields of drugs, pharmaceuticals and medicines, and in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing; researching and developing new products in the fields of drugs, pharmaceuticals and medicines; scientific research and development services in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing; preparation of reports of scientific and medical research concerning drugs, pharmaceuticals, medicines, genetics, biology and biotechnology; development and design of medical or scientific prognostic and diagnostic apparatus and instruments; consultancy and information services relating to all of the aforesaid

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 22, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameWisTa Laboratories Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSingapore 658066
SG

Party NameWisTa Laboratories Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSingapore 658066
SG

Party NameWisTa Laboratories Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSingapore 658066
SG

Trademark Events


Event DateEvent Description
Monday, April 11, 2016ASSIGNED TO EXAMINER
Monday, February 22, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, February 23, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 27, 2016APPLICATION FILING RECEIPT MAILED
Thursday, April 14, 2016NON-FINAL ACTION WRITTEN
Friday, April 15, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 15, 2016REFUSAL PROCESSED BY MPU
Friday, April 15, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 13, 2016REFUSAL PROCESSED BY IB
Friday, September 2, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 10, 2016ASSIGNED TO LIE
Thursday, September 15, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 15, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 6, 2016NON-FINAL ACTION E-MAILED
Thursday, October 6, 2016NON-FINAL ACTION WRITTEN
Thursday, October 6, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 3, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 3, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 3, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 20, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, June 7, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, June 19, 2017FINAL DISPOSITION PROCESSED
Saturday, November 5, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 16, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 30, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 20, 2016PUBLISHED FOR OPPOSITION
Monday, June 19, 2017FINAL DISPOSITION NOTICE SENT TO IB
Monday, March 7, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, September 22, 2023CANCELLED SECTION 71
Friday, June 14, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, June 24, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, June 24, 2024INVALIDATION PROCESSED
Saturday, July 8, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, July 14, 2024TOTAL INVALIDATION PROCESSED BY THE IB